Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 03:00PM GMT
Release Date Price: $48.14 (-0.74%)
Mark Douglas Purcell;Dietmar P. Berger
Morgan Stanley, Research Division - Equity Analyst;Sanofi -

So good morning and good afternoon, everyone. My name is Mark Purcell. I'm one of the analysts at Morgan Stanley covering European Biopharma. It gives me great pleasure to introduce Sanofi today. We have 2 speakers: Dietmar Berger, who's SVP, Global Head of Development and the Chief Medical Officer of Sanofi; and also Brian Foard, who's the Global Head of Dermatology and Respiratory. We're also supported by the IR team. We've got Felix, Arnaud and Eva there in the background.

(Operator Instructions) For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any other questions, please reach out to your Morgan Stanley sales representative.

So without further ado, Dietmar, I'll hand over to you for some introductory remarks, and then we'll sort of start going through the Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot